Tag: Drugs and Pharmaceuticals
Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID-19 Vaccine Under Fast Track CARES Act
eNewsChannels NEWS: -- Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx2 Delivery Platform.
Avila Herbals Announces Research and Development Agreements with Phoenix Biotechnology
eNewsChannels NEWS: -- Avila Herbals, a company specializing in novel botanical extraction techniques for both dietary supplements and pharmaceuticals, announced today that it has signed an exclusive global manufacturing agreement and a research and development agreement with Phoenix Biotechnology.
Leading Infectious Disease Research Scientist Michael Mansour, MD, PhD To Serve as Medical Advisor for NED Biosystems
eNewsChannels NEWS: -- NED Biosystems, an innovative clinical-stage biotech company developing therapies for cancer and the novel coronavirus, is pleased to announce that Michael Mansour, MD, PhD, will serve as the Company's Medical Advisor of Infectious Disease.
US Pharmaceutical Corporation Introduces Patented Hylafem pH Vaginal Suppositories Consisting of Boric Acid in a Probiotic Blend
eNewsChannels NEWS: -- US Pharmaceutical Corporation, the probiotic and nutritional supplement company, launches Hylafem pH vaginal suppositories, a unique, patented, homeopathic suppository product which efficaciously tackles recurring women's vaginal health issues.
To Focus on Pharmaceutical Purification Market, Thar Process Inc. Expands into India
eNewsChannels NEWS: -- Thar Process, Inc - an American manufacturer of high-tech supercritical CO2 extraction and purification equipment - is proud to announce the signing of a new exclusive distribution deal with YMC India (a subsidiary of YMC Co. Ltd., JAPAN).
Aristea Translational Medicine Corp: launches Novel Treatment Approach to Silent Hypoxia in SARS-CoV-2 Patients
eNewsChannels NEWS: -- Silent Hypoxia is a frequent disabling and sometimes fatal complication in COVID-19 disease. To prevent SARS-CoV-2 coronavirus-induced damage to patients' lungs and Silent Hypoxia in patients, Aristea Translational Medicine Corp. has initiated development of PhenT, a drug with novel cellular protective properties.
ROKiT Pharma’s Preclinical Studies Showing Promise for Naturally Derived Cancer Drug, ROK-001 – Moving Towards Phase 1b/2 Clinical Trial
eNewsChannels NEWS: -- ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural ingredients.
Pennsylvania’s Boothwyn Pharmacy in Kennett Square Now Manufacturing Hand Sanitizer
eNewsChannels NEWS: -- Boothwyn Pharmacy, a PCAB-accredited compounding pharmacy located mere minutes from the heart of Kennett Square, Pennsylvania, has dedicated resources to manufacture hand sanitizer.
EPIC Continues Expansion of Employee Benefits Practice for 2020 in New York
eNewsChannels NEWS: -- EPIC Insurance Brokers and Consultants, a retail property, casualty insurance brokerage and employee benefits consultant, announced today they are continuing to expand their employee benefits resources with the addition of a new Pharmacy Practice Leader, Bob Eisendrath.
American Society of Hematology Annual Meeting: iCell Gene Therapeutics Announces CAR-T Oral and Poster Presentations
eNewsChannels NEWS: -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of Hematology (ASH) Annual Meeting to be held December 7-10, 2019 in Orlando, Florida.
